Different induction of gulonolactone oxidase in aromatic hydrocarbon-responsive or -unresponsive mouse strains  by Braun, László et al.
Di¡erent induction of gulonolactone oxidase in aromatic
hydrocarbon-responsive or -unresponsive mouse strains
La¤szlo¤ Braun, Tama¤s Kardon, Karim El Koulali, Miklo¤s Csala, Jo¤zsef Mandl,
Ga¤bor Ba¤nhegyi*
Department of Medical Chemistry, Semmelweis University of Medicine, P.O. Box 260, H-1444 Budapest, Hungary
Received 9 November 1999
Edited by Barry Halliwell
Abstract The role of aromatic hydrocarbon receptor (AhR)-
mediated signal transduction pathways was investigated in the
regulation of ascorbate synthesis by using Ah-responsive and Ah-
unresponsive mouse strains. In vivo 3-methylcholanthrene treat-
ment increased hepatic and plasma ascorbate concentrations only
in the Ah-responsive strain. The mRNA level of gulonolactone
oxidase and the microsomal ascorbate production from p-
nitrophenyl glucuronide, D-glucuronic acid or gulonolactone in
the liver of Ah-responsive and Ah-unresponsive mice were
compared. In Ah-responsive mice, these parameters were higher
originally, and they further increased upon in vivo addition of 3-
methylcholanthrene, while in Ah-unresponsive mice the treatment
was not effective. These results suggest that the transcription of
gulonolactone oxidase gene is regulated by an Ah receptor-
dependent signal transduction pathway.
z 1999 Federation of European Biochemical Societies.
Key words: Ascorbate; Gulonolactone oxidase; Aromatic
hydrocarbon receptor; Glucuronide; 3-Methylcholanthrene
1. Introduction
Ascorbate is a major water-soluble antioxidant of the cell
[1]. The maintenance of the adequate level of tissue ascorbate
pools is of vital importance as can be seen in scurvy. The last
step of ascorbate synthesis is catalysed by L-gulono-Q-lactone
oxidase, which produces ascorbate and hydrogen peroxide
[1,2]. In ascorbate-synthesising species (i.e. in the majority of
animals, except for primates and some other species) the reg-
ulation of the enzyme may be responsible for the tuning of
ascorbate level. In fact, it has been reported that L-gulono-Q-
lactone oxidase (GLO) activity can be altered by end-product
inhibition [3]. Other studies demonstrated that ascorbate syn-
thesis is stimulated by the administration of a variety of xeno-
biotics including 3-methylcholanthrene (3-MC) [4^6]. Carcino-
genic polycyclic aromatic hydrocarbons, such as 3-MC, are
archetypical inducers of the genes belonging to the aromatic
hydrocarbon-responsive gene battery [7]. The upregulation of
UDP-glucuronosyltransferase 1A6 (UGT1A6), a member of
this gene battery by Ah inducers [8], is accompanied by in-
creased urinary excretion of ascorbate [9]. Therefore, the im-
portance of UGT1A6 induction in 3-MC-stimulated ascorbate
synthesis has been suggested [10]. Horio et al. proposed that
the ¢rst major precursor for microsomal ascorbate synthesis,
D-glucuronic acid is produced from UDP-glucuronic acid in-
volving X(phenol)-L-D-glucuronide formation catalysed by
UGT1A6 and the subsequent hydrolysis of the glucuronide
by L-glucuronidase [10,11].
Besides the above mechanism the direct transcriptional up-
regulation of microsomal ascorbate synthesising enzymes by
3-MC is also possible. As an AhR agonist stimulates ascor-
bate production it is a question whether the increased sub-
strate supply itself (by UGT1A6 induction) causes this phe-
nomenon or certain enzymes of ascorbate formation from D-
glucuronic acid are induced by an AhR-mediated signal trans-
duction pathway. In vivo experimental systems were chosen
for this study: two di¡erent mouse strains with di¡erent abil-
ities to respond to Ah stimulation. By genetic analysis, the Ah
locus appears to be complex consisting of at least two genes
with six di¡erent alleles, but in crosses between some mouse
strains (e.g. C57BL/6 Ah-responsive mice (B6) and DBA/2
Ah-unresponsive mice (D2)) the locus behaves as a single
Mendelian trait [12]. B6 mice are high responders and possess
high-a⁄nity aryl hydrocarbon receptors, whereas D2 mice are
low responders and have small amounts of detectable receptor
[12] or express identical amount of AhR but their ligand-bind-
ing a⁄nity is lower [13]. The microsomal ascorbate produc-
tion from D-glucuronic acid and the activity and expression of
GLO after in vivo 3-MC treatment were compared in the
livers of B6 and D2 mouse strains. Based on our ¢ndings
an AhR mediated GLO induction is proposed.
2. Materials and methods
2.1. Treatment of mice
Animals received human care according to the criteria outlined in
the ‘Guide for the Care and Use of Laboratory Animals’ prepared by
the National Academy of Sciences and published by the National
Institutes of Health, USA. Sexually immature (4^6-week-old) male
mice colonies from C57BL/6 (B6 as Ah-responsive) and DBA/2 (D2
as Ah-non-responsive) strains were provided by Charles River, Buda-
pest, Hungary and were housed in an animal room of our Department
with controlled temperature, humidity, pressure, dark-light cycle and
free access to standard food. Single injection of the inducing com-
pound 3-MC dissolved in corn oil (200^250 mg/body weight (kg))
was administered intraperitoneally. Control group of animals received
corn oil [12,13]. The dose of corn oil never exceeded 25 ml/kg body
weight.
2.2. Preparation and treatment of mouse liver microsomes
Liver microsomal vesicles were prepared from B6 and D2 male mice
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as previously described [16]. Microsomes were resuspended in 20 mM
4-morpholinepropanesulfonic acid (MOPS) (pH 7.2) containing 100
mM KCl, 20 mM NaCl, 3 mM MgCl2. The suspensions were frozen
and maintained under liquid nitrogen until used. In some series of
experiments vesicles were permeabilised by alamethicin using its opti-
mally activating concentration (0.05 mg/mg protein).
2.3. RNA extraction and Northern blotting with GLO probe
Total RNA was extracted from the liver of each mouse by the acid
guanidinium thiocyanate method [17]. The isolation of a rat GLO
cDNA was described previously [18]. An approximately 1 kb long
fragment of the rat GLO cDNA, designated 15L in pUC19 plasmid
[19] was kindly provided by Dr Morimitsu Nishikimi (Wakayama
Medical College, Department of Biochemistry, Wakayama, Japan).
15L and glyceraldehyde-3-phosphate dehydrogenase cDNA fragments
were denatured and labelled with [K-32P]dCTP using the High Prime
DNA labelling kit from Boehringer Mannheim. Then these were used
to probe the Northern blots. Northern blotting of RNA samples was
performed using essentially the method described by Sambrook et al.
[20].
2.4. Measurement of metabolites
Microsomes were incubated in 20 mM MOPS (pH 7.2) containing
100 mM KCl, 20 mM NaCl, 3 mM MgCl2. For the determination of
p-nitrophenol UGT1A6 activities, permeabilised mouse liver micro-
somes (0.1 mg protein/ml) were incubated in the presence of 5 mM
UDP-glucuronic acid and 500 WM p-nitrophenol for 30 min at 37‡C.
Incubations were terminated by the addition of 0.05 volume of 100%
trichloroacetic acid. p-Nitrophenol UGT1A6 activities were measured
spectrophotometrically on the basis of aglycone disappearance from
TCA soluble supernatants as previously described [21]. Cytochrome
P450 1A1 activity was measured in intact mouse microsomal vesicles
by 7-ethoxyresoru¢n O-deethylase assay according to the method of
Prough et al. [22]. Plasma and hepatic ascorbate content were meas-
ured by reverse phase HPLC following the speci¢c sample preparation
as described earlier [23]. For the determination of gulonolactone ox-
idase activity intact microsomal vesicles (usually 1 mg protein/ml)
were incubated in the presence of 5 mM gulonolactone for 30 min
at 37‡C. To determine ascorbate formation from D-glucuronic acid or
p-nitrophenyl glucuronide microsomes were permeabilised by ala-
methicin and were incubated in the presence of 5 mM ascorbate pre-
cursor with 5 mM NADPH for 30 min at 37‡C. Incubations were
terminated by the addition of 100% trichloroacetic acid (5% ¢nal
concentration). Ascorbate content was measured from trichloroacetic
acid soluble supernatants by the method of Omaye et al. [24], based
on the reduction of Fe3 with the oxidation of ascorbate and the
subsequent determination of the Fe2-K,KP-dipyridyl complex. L-Glu-
curonidase activities were detected in the presence of 5 mM p-nitro-
phenyl glucuronide; the formation of p-nitrophenol aglycone was
measured in the TCA soluble supernatants.
2.5. Miscellaneous
Protein concentration of microsomes was determined by using Bio-
Rad protein assay solution with bovine serum albumin as standard
according to manufacturers’ instructions. For the quantitation of the
amount of GLO mRNA, bands were scanned densitometrically. All
data were expressed as means þ S.E.M. Statistical analysis was carried
out by using Student’s t-test.
2.6. Materials
Alamethicin, K,KP-dipyridyl, D-glucuronic acid (sodium salt), L-gu-
lono-Q-lactone, 3-MC, MOPS, L-nicotinamide adenine dinucleotide
phosphate in reduced form, p-nitrophenyl-L-D-glucuronide, D-sac-
charic acid 1,4-lactone, and UDP-glucuronic acid (sodium salt) were
purchased from Sigma, St. Louis, MO, USA. WBondapak C18 HPLC
column (average particle size 10 WM, 300U4 mm I.D.) was obtained
from MZ-Analysentechnik, Mainz, Germany. Protein assay solution
and 3MM ¢lter papers were purchased from Bio-Rad Laboratories,
Budapest, Hungary. The Hybond-N nylon membrane and the Hyper-
¢lm were provided by Amersham International, Amersham, UK. The
K-32P-labelled dCTP was obtained from the Institute of Isotopes,
Budapest, Hungary. The High Prime DNA labelling kit was pur-
chased from Boehringer Mannheim, Mannheim, Germany. All other
chemicals and reagents were from Sigma and were of analytical grade
purity or better.
3. Results
3.1. Comparison of GLO induction by 3-MC in the livers of
C57BL/6 and DBA/2 mice
3-MC dissolved in corn oil or the pure solvent was admin-
istered to Ah-responsive B6 and Ah-unresponsive D2 mice.
The dose of 3-MC applied in the study was reported to be
optimally e¡ective in the induction of phase II enzymes of
biotransformation [15]. Microsomes and total RNA were pre-
pared from their livers. RNA samples underwent Northern
blot analysis using GLO probe. The amount of GLO
mRNA was signi¢cantly higher in the liver of 3-MC-treated
B6 mice compared to either corn-oil-treated B6- and D2-, or
3-MC-treated D2 mice indicating the intensive transcription
and/or stabilisation of GLO mRNA upon addition of 3-MC
in high responder B6 animals (Fig. 1). According to these
data, microsomal GLO activity was hardly stimulated by 3-
MC in Ah-unresponsive animals while in high responders
more than double elevation occurred (Table 1). The plasma
and hepatic ascorbate content exhibited approximately three-
fold elevation in B6 strain contrary to the moderate increase
in ascorbate concentration in the plasma and liver of D2 mice
upon addition of 3-MC (Table 1). In control experiments the
induction of enzymes known to be the members of the Ah-
battery was investigated. 7-ethoxyresoru¢n O-deethylase
(EROD) activity attributed to cytochrome P-450 1A1
(CYP1A1) showed more than 200-fold increase in B6 mice
Table 1
The e¡ect of 3-MC treatment on the microsomal GLO, CYP1A1 and UGT1A6 activities in the liver of Ah-responsive or Ah-unresponsive
mice
Strain Treatment Plasma ascorbate
concentration
(WM)
Hepatic ascorbate
content
(Wmol/g liver)
Gulonolactone
oxidase activity
(nmol/min/mg
microsomal protein)
EROD activity
(nmol/min/mg
microsomal
protein)
p-Nitrophenyl UGT
activity (nmol/min/
mg microsomal
protein)
DBA/2 (D2) Corn oil 20.5 þ 1.5 0.85 þ 0.02 1.96 þ 0.05 0.04 þ 0.004 20.2 þ 0.7
3-MC 35.5 þ 1.3b 1.37 þ 0.05b 2.85 þ 0.04b 0.09 þ 0.004b 25.3 þ 1.0b
C57BL/6 (B6) Corn oil 46.7 þ 0.8a 1.74 þ 0.02a 4.50 þ 0.07a 0.11 þ 0.008a 36.7 þ 1.3a
3-MC 154.2 þ 5.3a;b 5.06 þ 0.10a;b 9.97 þ 0.55a;b 24.73 þ 1.36a;b 64.5 þ 3.1a;b
DBA/2 and C57BL/6 male mice were treated with corn oil and 3-MC as detailed in Section 2. After the killing of the animals microsomal
vesicles were prepared from their livers according to Section 2. At the same time plasma ascorbate concentrations and hepatic ascorbate con-
tents were measured in each mouse. Gulonolactone oxidase, EROD (CYP1A1) and p-nitrophenyl UGT (UGT1A6) activities were determined
in each microsomal preparation as described in Section 2. For the measurement of UGT1A6 activities microsomal vesicles were permeabilised
by alamethicin (0.05 mg/mg protein). Data are expressed as means þ S.E.M. from four individual animals of various experimental groups.
aSigni¢cant di¡erences between the values of D2 and B6 mice: P6 0.01.
bSigni¢cant di¡erences from the corresponding controls: P6 0.01.
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while in D2 animals only 2.5-fold stimulation could be ob-
served indicating the expected response to 3-MC (Table 1).
Similarly to CYP1A1 the stimulation of p-nitrophenyl-UGT
activity as a function of UGT1A6 in Ah-responsive mice was
in accordance with previous observations (Table 1) [15].
To envisage the role of direct and indirect mechanisms in
the induction of GLO, the time-dependence of the induction
of EROD, p-nitrophenyl-UGT and GLO activities was
studied in Ah-responsive mice. The Ah-receptor activation
occurred early (after 6 h of 3-MC treatment) as it was re-
£ected in elevated EROD activities, while the increase in p-
nitrophenyl-UGT and GLO activities appeared later, 12 or 24
h after the treatment with 3-MC, respectively (Fig. 2).
Interestingly, in liver microsomes of corn oil-treated high
responder mice the basal GLO activity was more than two
times higher compared to the microsomes prepared from the
livers of low responder controls. Consequently, higher hepatic
ascorbate content and higher plasma ascorbate concentrations
were found in Ah-responsive corn oil-treated animals com-
pared to the D2 mice (Table 1). To determine whether the
enhanced initial GLO activity in B6 mice occurs at mRNA
level, total RNA was isolated from livers of both B6 and D2
controls and was subjected to Northern hybridisation with
GLO cDNA probe as described. The autoradiograph showed
a higher level of GLO mRNA in high responder controls
against corn oil-treated D2 mice (Fig. 1). A similar pattern
of di¡erence could be observed between the controls of the
two strains in the case of both EROD and p-nitrophenyl-
UGT activities (Table 1).
3.2. Ascorbate synthesis from p-nitrophenyl glucuronide or
D-glucuronic acid in liver microsomes from C57BL/6 and
DBA/2 mice treated with 3-MC
The e¡ect of 3-MC treatment on other microsomal enzymes
participating in the ascorbate synthetic pathway was also in-
vestigated. To bypass the AhR-regulated UGT1A6 activity, p-
nitrophenyl glucuronide or D-glucuronic acid were added to
microsomes as precursors for ascorbate synthesis. The vesicles
were permeabilised with the pore-forming agent alamethicin
[25] to promote the entry of the substrates into the intralumi-
nal space. Ascorbate formation from D-glucuronic acid or
from p-nitrophenyl glucuronide was higher in microsomes of
Ah-responsive mice compared to the other strain and it fur-
ther increased after 3-MC treatment (Table 2). According to
previous suggestions, L-glucuronidase can participate in ascor-
bate synthesis since the inhibition of L-glucuronidase by sac-
Fig. 1. The e¡ect of 3-MC treatment on GLO mRNA level in the
liver of mice belonging to Ah-responsive or unresponsive strains.
Total RNA (30 Wg/sample) isolated from control and 3-MC-treated
mice of both strain (B6, D2) was subjected to electrophoresis in
agarose gel containing formaldehyde followed by transfer to Hy-
bond-N nylon membrane as detailed earlier. The membrane was hy-
bridised with [K-32P]dCTP labelled GLO and GAPDH cDNA
probes, then autoradiography was used to visualise mRNAs. North-
ern blot analysis with GLO and GAPDH probe was carried out
with each RNA preparation from each animal involved in this ex-
periment and one of the typical results was presented. The results of
densitometric scanning of the GLO mRNA bands were also pre-
sented. Bars express average densities þ S.E.M. of mRNA bands
from four individual animals of various experimental groups. Lane
or bar 1, control D2; lane or bar 2, control B6; lane or bar 3, D2
treated with 3-MC; lane or bar 4, B6 treated with 3-MC. The den-
sity of B6 mRNA bands signi¢cantly di¡ered from the density of
D2 mRNA bands (aP6 0.01). The signi¢cant di¡erence from the
corresponding controls within each strain is also indicated
(bP6 0.01).
Fig. 2. The time course of the induction of CYP1A1, UGT1A6 and
GLO activities after 3-MC treatment in C57/BL6 mice. C57BL/6
male mice were treated with 3-MC as detailed in Section 2. Animals
were killed after various periods of the treatment and microsomal
vesicles were prepared from their livers according to the experimen-
tal section. Gulonolactone oxidase (O), EROD (CYP1A1) (E) and
p-nitrophenyl UGT (UGT1A6) (a) activities were determined in
each microsomal preparation as described in Section 2. For the
measurement of UGT1A6 activities microsomal vesicles were per-
meabilised by alamethicin (0.05 mg/mg protein). Data are expressed
as the percentage of initial activities. (For absolute values of initial
activities see the corn oil treated C57/BL6 (control) data of Table
1). Means þ S.E.M. of results from four animals
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charolactone [26] decreased ascorbate production from p-ni-
trophenyl glucuronide (Table 2). L-Glucuronidase activities
were similar in microsomes from both strains and remained
unchanged after 3-MC treatment, indicating that L-glucuroni-
dase is not responsible for the increased ascorbate synthesis.
4. Discussion
In the present study enhanced GLO activity was observed
after 3-MC administration in C57BL/6 mice known to be high
responders to AhR-dependent stimuli (Table 1), while in
DBA/2 mouse strain possessing low amounts of detectable
AhR and/or low-a⁄nity ligand-binding sites [12] this enzyme
activity could not be e⁄ciently stimulated (Table 1). Accord-
ing to the Northern analysis the elevation in GLO activity in
3-MC-treated B6 mice can be explained by the increase in
GLO mRNA (Fig. 1).
In contrast to the present study it has been reported pre-
viously that GLO mRNA level remains una¡ected by 3-MC
in rats [11]. The non-responsiveness of rat GLO gene in 3-MC
treatment can be explained by the mutations of AhR-AhR
nuclear translocator (Arnt) dimer-speci¢c core sequences
within the E-boxes, which occurred in the promoter of rat
GLO, or by the TATA box-free promoter of this gene
[11,27]. The necessity of TATA box in enhancer/promoter
communication during the AhR-mediated induction of
CYP1A1 is well described [7].
The role of AhR in the regulation of GLO expression was
emphasised by the comparison of basal values detected in
corn oil-treated controls of both strains. The original hepatic
and plasma ascorbate levels, as well as the original rate of
GLO activities and mRNA levels were signi¢cantly lower in
Ah-insensitive control mice than in high responders (Table 1
and Fig. 1) similarly to the behaviour of well-known Ah-bat-
tery elements: CYP1A1 and UGT1A6 (Table 1). It may be
supposed that in Ah-responsive animals the ligands of the
AhR can induce the members of the Ah-battery, including
GLO.
The enzymes of the Ah-battery may stay under dual tran-
scriptional control: (1) the direct AhR-mediated pathway and/
or (2) oxidative stress-initiated route due to the phase I me-
tabolism of AhR ligands and stimulation of electrophile re-
sponse element of phase II genes [8]. In several cases the two
groups of regulatory elements may overlap. On the basis of
the time-dependence of UGT1A6 and GLO induction the in-
volvement of secondary mechanisms is also supposed; their
induction is lagging compaired to the induction of the EROD
activity. However, the time course of the induction of both
UGT1A6 and GLO shows a similar pattern; and the AhR-
dependent induction of UGT1A6 has been veri¢ed [8].
It has been assumed that the Ah-stimulated ascorbate pro-
duction was caused by AhR-inducible UGT1A6 and L-glucu-
ronidase [10]. The microsomal ascorbate formation from both
p-nitrophenyl glucuronide and D-glucuronic acid was higher in
control Ah-responder mice and it could be stimulated further
by 3-MC treatment only in these animals indicating the exis-
tence of an inducible step located after L-glucuronidase (Table
2). The close correlation between UGT1A6 and GLO activ-
ities calculated from the data of Table 1 refers to the same
inductive states of these two enzymes which can be explained
by their common regulatory mechanism: the AhR-dependent
way. The prevention of ascorbate synthesis from p-nitrophen-
yl glucuronide by the inhibition of L-glucuronidase (Table 2)
supports the importance of AhR-regulated UGT1A6 in the
substrate supply of Ah-stimulated ascorbate synthesis as pro-
posed by Horio et al. [10,11]. It has been also reported that
phenobarbital treatment of rats enhanced hepatic ascorbate
level without any e¡ect on GLO activity. It could be explained
by the induction of several UGTs increasing the level of glu-
curonides and consequently the glucuronic acid supply for
ascorbate synthesis [11].
In summary, we concluded that gulonolactone oxidase may
be a target for the AhR-mediated signal transduction path-
way. Further work is needed to evaluate the contribution of
direct or indirect mechanisms of the AhR-dependent tran-
scriptional activation to enhanced ascorbate synthesis.
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Table 2
Microsomal ascorbate formation from glucuronic acid or p-nitrophenyl glucuronide in the presence or absence of saccharolactone in the liver
of 3-MC treated Ah-responsive and Ah-unresponsive mice
Strain Treatment Ascorbate formation from
5 mM D-glucuronic acid
(nmol/min/mg protein)
Ascorbate formation from
5 mM p-nitrophenyl glucuronide
(nmol/min/mg protein)
L-Glucuronidase activity
(5 mM p-nitrophenyl glucuronide)
(nmol/min/mg protein)
3Saccharolactone +Saccharolactone 3Saccharolactone +Saccharolactone
DBA/2 (D2) corn oil 0.08 þ 0.01 0.08 þ 0.01 0.040 þ 0.003c 1.66 þ 0.06 0.69 þ 0.03c
3-MC 0.10 þ 0.01b 0.08 þ 0.01 0.047 þ 0.003c 1.71 þ 0.06 0.75 þ 0.01c
C57BL/6 (B6) corn oil 0.14 þ 0.01a 0.12 þ 0.01a 0.043 þ 0.004c 1.71 þ 0.04 0.70 þ 0.02c
3-MC 0.26 þ 0.01a;b 0.27 þ 0.01a;b 0.047 þ 0.008c 1.66 þ 0.03 0.73 þ 0.01c
Liver microsomes were prepared from the corn oil-, and 3-MC treated D2 or B6 male mice according to Section 2. 5 mM NADPH was added
to alamethicin permeabilised vesicles (0.05 mg/mg protein) and ascorbate formation from 5 mM D-glucuronic acid or 5 mM p-nitrophenyl glu-
curonide were measured. Ascorbate formation from p-nitrophenyl glucuronide was determined both in the presence and absence of 10 mM sac-
charolactone simultaneously with L-glucuronidase activities as described earlier. Data are expressed as means þ S.E.M. from four individual ani-
mals of various experimental groups. Signi¢cant di¡erences between the values of D2 and B6 mice: aP6 0.01; signi¢cant di¡erences from the
corresponding controls: bP6 0.01.
aSigni¢cant di¡erences between the values of D2 and B6 mice: P6 0.01.
bSigni¢cant di¡erences from the corresponding controls: P6 0.01.
cStatistically signi¢cant di¡erences of values obtained from saccharolactone treated microsomes versus normal incubations: P6 0.01.
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